According to Diabetes UK, around 200,000 people are diagnosed with type 2 diabetes every year and there are 3.5 million people in England with a diagnosis. The increasing number of people with type 2 diabetes is a challenge to the NHS and healthcare systems across the world. It is a leading cause of sight loss and lower limb amputation, and can contribute to kidney failure, heart attack and stroke. Diabetes and its complications cost over £6 billion every year to treat and one in six patients in hospital now has diabetes.1
In this week’s article we provide our usual monthly roundup of some of the most recent health and nutrition related articles to be in the news, five items comprising:
- Illnesses associated with lifestyle cost the NHS £11bn
- Probiotics may ease severity of multiple sclerosis: Study
- Could Turmeric really boost your health?
- Mediterranean diet ‘could prevent 19,000 deaths a year in UK’
- Feeding babies peanuts and eggs can reduce risk of developing allergies in later life, study shows
“Results of longitudinal studies suggest that depression, general emotional stress and anxiety, sleeping problems, anger and hostility are associated with an increased risk for the development of Type 2 Diabetes”, commented a report back in 2010 by the European Depression in Diabetes Research Consortium.
In the past 30 or so years researchers and food manufacturers have become increasingly interested in a certain type of antioxidant, known as polyphenols, and the role that they play in the body. The main reason for this interest stems from the antioxidant properties of polyphenols, their great abundance in our diet, and their probable role, backed up by much research, in the prevention of various diseases associated with oxidative stress, such as cancer and cardiovascular and neuro-degenerative diseases.
It states on the National Institute of Diabetes website that most people who are suffering from insulin resistance don’t realise that they have the condition until they eventually develop Type 2 Diabetes.
Alzheimer’s disease has long been a condition of catastrophic consequences; a condition affecting around 26 million people worldwide, a high number of fatalities and a severe financial burden upon healthcare throughout the Western world. But need this be the case?